Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

HLA-DRB5 and other genes may be linked to alopecia universalis.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.